Interested in the Cineworld share price? Here’s all you need to know

Is Cineworld the bargain of the century? Tom Rodgers investigates the ins and outs of the world’s second-biggest cinema chain.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Investing in Cineworld (LSE:CINE) at any time in 2020 has been a very costly endeavour. But could buying shares in the cinema giant now be the bargain of the century?

This is a household name. You’ll find Cineworld cinemas in almost every major town and city in the country. So seeing the Cineworld share price bumping around below 25p? It’s likely to activate the ‘screaming bargain’ centres of the average investor’s brain.

After all, doesn’t Warren Buffett suggest we should be greedy when others are fearful?

So this is the question I will answer today: is the Cineworld share price massively undervalued?

Opening crawl

The Cineworld share price has plummeted more than 87% since the end of last year. At Christmas 2019 all seemed to be going rather swimmingly for the mega-chain.

It had a £1.3bn deal in the offing to buy out its Canadian rival Cineplex. This would give the FTSE 250 company a massive new market and 1,670 extra screens across 167 theatres. A year earlier it had created the world’s second-largest cinema chain with a massive £2.4bn buyout of rival Regal cinemas.

Then the pandemic happened. As a business that relies on packing as many people into a space as possible, it could not have come at a worse time. Every single venue closed: 787 cinemas across 10 countries.

An April 2020 decision by Cineworld to stop paying directors’ salaries and suspend future dividends was seen as a prudent financial move. But only because such heavy debts had piled up in the background.

Middle row

The company reported on 24 September 2020 it had swung to a $1.64bn loss in the first half of the year, compared to a $172m profit in the first half of 2019. Its shares slid a further 12% in a day, indicating exhaustion from shareholders with these sharp falls.

The lead analyst for CMC Markets, Michael Hewson, said these shocking numbers “serve to highlight the scale of the mountain that needs to be scaled“, but did at least reinforce the decision to pull out of the Cineplex takeover.

The problem now, of course, is that Cineworld is facing a massive and costly lawsuit for pulling out of that mega-deal. It has countersued, but this could be a fight that lingers for years.

Debtor’s prism

Credit ratings agencies like Fitch, Moody’s, and S&P, who measure how likely a company is to be able to repay its debts, have been scathing.

S&P has downgraded Cineworld to CCC+, its lowest possible rating, while according to Moodys, leverage is up from 5.5 times Cineworld’s annual earnings in 2019 to over 9 times earnings in 2020. These are numbers as investors we do not want to see. These are scary levels of debt.

The only real hope for a turnaround now is a takeover from another cinema chain. But the gargantuan debt pile — which any new owner would have to take on — is likely to keep buyers away.

Cineworld leader?

The Cineworld share price is likely to remain very volatile, swinging back and forth by large percentages every day. And its long-term outlook is worse than poor. It’s bleak.

So I would suggest this share is only really of interest to day traders and short-sellers, who profit most when a company’s share price falls dramatically.

There are better places for your hard-earned cash today. I would avoid.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

TomRodgers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »